News Releases

ACS CAN Comments Call FDA’s Proposal to Reclassify Tanning Beds a Step in the Right Direction

Additional regulation critical to minimize harmful effects of indoor tanning devices

August 1, 2013

WASHINGTON, DC – August 1, 2013 – The American Cancer Society Cancer Action Network (ACS CAN) today submitted comments to the Food and Drug Administration (FDA) commending the agency for its proposal to reclassify tanning devices to address safety concerns associated with indoor tanning, but called for stronger guidance to best protect young adults from the most important avoidable known risk factor for skin cancer. The comments explained that by increasing the risk category of these devices to a class II medical device, the FDA will improve safety for consumers by ensuring that proper precautions are taken to prevent injury due to mechanical problems, ensure cleanliness, address eye safety, and update warning labels. ACS CAN urged the FDA to go a step further and restrict tanning bed access to all young adults under the age of 18.

“Given what we know about the harmful effects of indoor tanning devices, we believe that additional warning labels, even ones specifically geared toward those who are under age 18, do not go far enough in protecting America’s youth from the harmful effects of indoor tanning devices,” the letter stated.

For the full comment letter, visit:

A group of nine U.S. Senators sent a letter to FDA Commissioner Margaret Hamburg last week urging the FDA to finalize its proposed order to reclassify tanning beds and restrict minors from using and purchasing sunlamps as health issues from these devices continue to grow. For full text of the letter, visit:

ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem.  ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visit

Lauren Walens or Steven Weiss
American Cancer Society Cancer Action Network
Phone: (202) 661-5763 or (202) 661-5711
Email: or

#tanning #skincancer #cancer #FDA #tanningbed #ACSCAN

For media inquiries, please contact:
Alissa Crispino
Phone: (202) 661-5772

Jill Courtney
Phone: (202) 585-3278

link to email ACS CAN to subscribe to our distribution list.


ACS CAN is the nation's leading cancer advocacy organization that is working every day to make cancer issues a national priority. More

Learn About Our Issues

Find Cancer Information At